ArticleFrontiers in pharmacology2026
Reduced-order modeling of solute transport within physiologically realistic solid tumor microenvironment.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Solid tumors are characterized by densely packed extracellular matrices and limited vascularization, creating significant resistance to both diffusive and convective transport. Tumor growth depends on complex flow-structure interactions across multiple scales, while vascular abnormalities and enhanced permeability elevate interstitial pressure in the tumor microenvironment. Methods: In this study, we developed an integrated computational framework with a theoretical modeling framework that couples three phase, viscous-laminar, transient simulations of glycocalyx-patched tumor vessel-resolving plasma, red blood cells (RBCs), and white blood cells (WBCs) and tracking their volume fractions with a calibrated reverse advection-diffusion (RAD) model for intratumoral plasma transport. The reduced-order tumor microenvironment model incorporates electrohydrodynamic (EHD) force at the tumor vessel wall via glycocalyx patches on the luminal surface. Results: At the fenestra, EHD increases inlet plasma intensity relative to a non-EHD framework across all 15 numerical models (means: 0.576 non-EHD vs. 0.722 EHD; gain Discussion: By using fully resolved, EHD-inclusive multiphase CFD simulations to calibrate a reduced-order RAD model parameterized by measurable geometric features, we bridge the gap between classical Darcy-Starling perfusion models and fully resolved CFD. The resulting framework provides a tractable mechanism-grounded tool for quantifying plasma progression in dense solid tumors and for establishing the baseline transport capacity of the tumor extracellular matrix, independent of solute-specific biochemical properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.